254 related articles for article (PubMed ID: 20233869)
1. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer.
Min Y; Ren X; Vaught DB; Chen J; Donnelly E; Lynch CC; Lin PC
Cancer Res; 2010 Apr; 70(7):2819-28. PubMed ID: 20233869
[TBL] [Abstract][Full Text] [Related]
2. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
[TBL] [Abstract][Full Text] [Related]
3. Proline/arginine-rich end leucine-rich repeat protein N-terminus is a novel osteoclast antagonist that counteracts bone loss.
Rucci N; Capulli M; Ventura L; Angelucci A; Peruzzi B; Tillgren V; Muraca M; Heinegård D; Teti A
J Bone Miner Res; 2013 Sep; 28(9):1912-24. PubMed ID: 23559035
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface.
Nannuru KC; Futakuchi M; Varney ML; Vincent TM; Marcusson EG; Singh RK
Cancer Res; 2010 May; 70(9):3494-504. PubMed ID: 20406980
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis inhibitor TNP-470 inhibits human breast cancer osteolytic bone metastasis in nude mice through the reduction of bone resorption.
Sasaki A; Alcalde RE; Nishiyama A; Lim DD; Mese H; Akedo H; Matsumura T
Cancer Res; 1998 Feb; 58(3):462-7. PubMed ID: 9458090
[TBL] [Abstract][Full Text] [Related]
6. Sagopilone inhibits breast cancer bone metastasis and bone destruction due to simultaneous inhibition of both tumor growth and bone resorption.
Strube A; Hoffmann J; Stepina E; Hauff P; Klar U; Käkönen SM
Clin Cancer Res; 2009 Jun; 15(11):3751-9. PubMed ID: 19470728
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.
Park BK; Zhang H; Zeng Q; Dai J; Keller ET; Giordano T; Gu K; Shah V; Pei L; Zarbo RJ; McCauley L; Shi S; Chen S; Wang CY
Nat Med; 2007 Jan; 13(1):62-9. PubMed ID: 17159986
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic role of connective tissue growth factor (CTGF/CCN2) in osteolytic metastasis of breast cancer.
Shimo T; Kubota S; Yoshioka N; Ibaragi S; Isowa S; Eguchi T; Sasaki A; Takigawa M
J Bone Miner Res; 2006 Jul; 21(7):1045-59. PubMed ID: 16813525
[TBL] [Abstract][Full Text] [Related]
9. PTHrP regulates angiogenesis and bone resorption via VEGF expression.
Isowa S; Shimo T; Ibaragi S; Kurio N; Okui T; Matsubara K; Hassan NM; Kishimoto K; Sasaki A
Anticancer Res; 2010 Jul; 30(7):2755-67. PubMed ID: 20683010
[TBL] [Abstract][Full Text] [Related]
10. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis.
Pollari S; Käkönen SM; Edgren H; Wolf M; Kohonen P; Sara H; Guise T; Nees M; Kallioniemi O
Breast Cancer Res Treat; 2011 Jan; 125(2):421-30. PubMed ID: 20352489
[TBL] [Abstract][Full Text] [Related]
11. Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer.
Liu J; Li D; Dang L; Liang C; Guo B; Lu C; He X; Cheung HY; He B; Liu B; Li F; Lu J; Wang L; Shaikh AB; Jiang F; Lu C; Peng S; Zhang Z; Zhang BT; Pan X; Xiao L; Lu A; Zhang G
Sci Rep; 2017 Jan; 7():40487. PubMed ID: 28071724
[TBL] [Abstract][Full Text] [Related]
12. What Is Breast in the Bone?
Shemanko CS; Cong Y; Forsyth A
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27782069
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog signaling induced by breast cancer cells promotes osteoclastogenesis and osteolysis.
Das S; Samant RS; Shevde LA
J Biol Chem; 2011 Mar; 286(11):9612-22. PubMed ID: 21169638
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 stimulation of osteoclastogenesis and bone resorption is a mechanism for the increased osteolysis of metastatic bone disease.
Bendre MS; Montague DC; Peery T; Akel NS; Gaddy D; Suva LJ
Bone; 2003 Jul; 33(1):28-37. PubMed ID: 12919697
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis.
Guise TA; Yin JJ; Taylor SD; Kumagai Y; Dallas M; Boyce BF; Yoneda T; Mundy GR
J Clin Invest; 1996 Oct; 98(7):1544-9. PubMed ID: 8833902
[TBL] [Abstract][Full Text] [Related]
16. Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling.
Hsieh CJ; Kuo PL; Hou MF; Hung JY; Chang FR; Hsu YC; Huang YF; Tsai EM; Hsu YL
Int J Oncol; 2015 Feb; 46(2):555-62. PubMed ID: 25421824
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo.
Idris AI; Libouban H; Nyangoga H; Landao-Bassonga E; Chappard D; Ralston SH
Mol Cancer Ther; 2009 Aug; 8(8):2339-47. PubMed ID: 19671767
[TBL] [Abstract][Full Text] [Related]
18. Cathepsin G enhances mammary tumor-induced osteolysis by generating soluble receptor activator of nuclear factor-kappaB ligand.
Wilson TJ; Nannuru KC; Futakuchi M; Sadanandam A; Singh RK
Cancer Res; 2008 Jul; 68(14):5803-11. PubMed ID: 18632634
[TBL] [Abstract][Full Text] [Related]
19. Targeted overexpression of BSP in osteoclasts promotes bone metastasis of breast cancer cells.
Tu Q; Zhang J; Fix A; Brewer E; Li YP; Zhang ZY; Chen J
J Cell Physiol; 2009 Jan; 218(1):135-45. PubMed ID: 18756497
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
